Early diagnosis through HPV testing can alleviate financial pressures on families and healthcare systems, enabling women to remain active contributors to their families and economies.

Metropolis Healthcare has collaborated with Roche Diagnostics India to introduce a self-sampling human papillomavirus (HPV) DNA test for cervical cancer screening. “The self-sampling HPV DNA ...

However, they face disproportionate health risks, including cervical cancer caused by the Human Papillomavirus (HPV). Traditional pap smear testing has limitations, including low sensitivity and ...

Metropolis Healthcare Limited on Monday announced its collaboration with Roche Diagnostics India and Neighbouring Markets to introduce the self-sampling human papillomavirus (HPV) DNA test for ...

Sufficient scientific evidence exists to recommend HPV DNA testing in the triage of women with equivocal cytology and in follow-up after the treatment of precursor lesions. However, due to a low ...

According to estimates, for every 100 mothers who die from cervical or breast cancer in resource-poor settings, 14 children die before their 10th birthday, and 210 become maternal orphans. Be part ...

The HPV DNA test, recognized by the World Health Organization (WHO) as a first-choice screening method for cervical cancer prevention3, can help bridge the gap. This cutting-edge test detects 14 ...

today announced its collaboration with Roche Diagnostics India and Neighbouring Markets to introduce the self-sampling human papillomavirus (HPV) DNA test for cervical cancer screening.

Many women who test positive for HPV with negative cytology do not receive follow-up testing. Clinicians must eliminate barriers to retesting and clearly communicate the risk for developing ...